Journal of Neurosurgery February 2017

Responses to ARUBA: a systematic review and critical analysis for the design of future arteriovenous malformation trials

Incidence and predictors of dural venous sinus pressure gradient in idiopathic intracranial hypertension and non-idiopathic intracranial hypertension headache patients: results from 164 cerebral venograms

Fracture and migration of a retained wire into the thoracic cavity after endovascular neurointervention: report of 2 cases

Endovascular therapy of low– and intermediate-grade intracranial lateral dural arteriovenousfistulas: a detailed analysis of primary success rates, complication rates, and long-termfollow-up of different technical approaches

Racial disparities in the diagnosis and management of trigeminal neuralgia

Update: Journals of Neurosurgical Interest ordered by citation:

Journals of Neurosurgical Interest ordered by citation:

Neurosurgery January 2017















Journal of Neurosurgery: January 2017

A randomized controlledtrial comparing autologous cranioplasty with custom-made titanium cranioplasty.

Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease

Presentation and management of lateral sinus thrombosis following posterior fossa surgery

The impact of hybrid neurosurgeons on the outcomes of endovascular coiling for unruptured cerebral aneurysms

Stereotactic radiosurgery for cerebral arteriovenous malformations: evaluation of long-term outcomes in a multicenter cohort


From January 1st 2017, Neurosurgery, will be published by Oxford University Press. The journal will be available at

Oxford University Press (OUP) is pleased to announce its new partnership with the Congress of Neurological Surgeons (CNS). Beginning in January 2017, OUP will publish Neurosurgery and Operative Neurosurgery (ONS).

“OUP is a great fit for us,” said Alan M. Scarrow, MD, president of the CNS. “As one of the leading publishers in the world, OUP combines a rich research heritage with a unique ability to leverage today’s digital technology. We are excited about their ability to provide creative and innovative solutions for us and look forward to forging a path of growth together.”

Featuring original, peer-reviewed articles, Neurosurgery is the fastest-growing journal in the field, with a worldwide reputation for reliable coverage delivered with a fresh and dynamic outlook. Neurosurgery attracts contributions from the most respected international authorities and presents the latest in clinical and experimental neurosurgery. Applicable to both researchers and practicing neurosurgeons, the journal includes a wealth of valuable, in-depth information that is applicable to researchers and practicing neurosurgeons alike.

ONS is a unique publication focusing exclusively on surgical technique and devices, providing practical, cutting-edge, and skill-enhancing guidance to its readers. Complementing the clinical and research studies published in Neurosurgery, ONS brings the reader technical material that highlights operative procedures, anatomy, instrumentation, devices, and technology.

“2016 has been a banner year for the journals, and as we all work to ensure continued success and innovation, I cannot think of a better partner than Oxford University Press,” said Nelson M. Oyesiku, MD, editor in chief of Neurosurgery and Operative Neurosurgery. “We all look forward to a long and fruitful partnership.”

“We are very excited to be partnering with the Congress of Neurological Surgeons to publish Neurosurgery and Operative Neurosurgery. OUP shares the CNS’s mission-driven approach and its goal to make Neurosurgery and Operative Neurosurgery the standout journals in their field,” said Christopher Reid, senior publisher at Oxford University Press.

About Oxford Journals

Oxford Journals is a division of Oxford University Press, which publishes over 300 academic and research journals covering a broad range of subject areas, two thirds of which are published in collaboration with learned societies and other international organizations. Oxford Journals has been publishing journals for more than a century and, as part of the world’s oldest and largest university press, has more than 500 years of publishing expertise behind it.

About Oxford University Press

Oxford University Press is a department of the University of Oxford. It furthers the University’s objective of excellence in research, scholarship, and education by publishing worldwide. OUP is the world’s largest university press with the widest global presence. It currently publishes more than 6,000 new publications a year, has offices in around fifty countries, and employs more than 5,500 people worldwide. It has become familiar to millions through a diverse publishing program that includes scholarly works in all academic disciplines, bibles, music, school and college textbooks, business books, dictionaries and reference books, and academic journals.

About the Congress of Neurological Surgeons

The Congress of Neurological Surgeons (CNS) is the largest neurosurgical society in the world and the global leader in neurosurgical education, serving to promote health by advancing neurosurgery through innovation and excellence in education. The CNS provides leadership in neurosurgery by inspiring and facilitating scientific discovery and its translation into clinical practice. The CNS maintains the vitality of the profession through volunteer efforts of its members and the development of leadership in service to the public, to colleagues in other disciplines, and to neurosurgeons throughout the world in all stages of their professional lives. For more information, visit

About Neurosurgery

Neurosurgery, an official journal of the Congress of Neurological Surgeons, is the most complete window to the contemporary field of neurosurgery. Members of the CNS and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world’s most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable.

Impact Factor
5 year Impact Factor
SI: Surgery
12 out of 199


Nelson M. Oyesiku

Editorial Board

Neuro-Oncology January 2017

1: Antonios JP, Soto H, Everson RG, Moughon D, Orpilla JR, Shin NP, Sedighim S,
Treger J, Odesa S, Tucker A, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM.
Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune
resistance via a PD-1/PD-L1 mechanism in glioblastoma. Neuro Oncol. 2017 Jan 23.
pii: now287. doi: 10.1093/neuonc/now287. [Epub ahead of print] PubMed PMID:

2: Ramkissoon SH, Bandopadhayay P, Hwang J, Ramkissoon LA, Greenwald NF,
Schumacher SE, O’Rourke R, Pinches N, Ho P, Malkin H, Sinai C, Filbin M, Plant A,
Bi WL, Chang MS, Yang E, Wright KD, Manley PE, Ducar M, Alexandrescu S, Lidov H,
Delalle I, Goumnerova LC, Church AJ, Janeway KA, Harris MH, MacConaill LE,
Folkerth RD, Lindeman NI, Stiles CD, Kieran MW, Ligon AH, Santagata S, Dubuc AM,
Chi SN, Beroukhim R, Ligon KL. Clinical targeted exome-based sequencing in
combination with genome-wide copy number profiling: precision medicine analysis
of 203 pediatric brain tumors. Neuro Oncol. 2017 Jan 19. pii: now294. doi:
10.1093/neuonc/now294. [Epub ahead of print] PubMed PMID: 28104717.

3: Berghoff AS, Wolpert F, Holland-Letz T, Koller R, Widhalm G, Gatterbauer B,
Dieckmann K, Birner P, Bartsch R, Zielinski CC, Weller M, Preusser M. Combining
standard clinical blood values for improving survival prediction in patients with
newly diagnosed brain metastases-development and validation of the LabBM score.
Neuro Oncol. 2017 Jan 17. pii: now290. doi: 10.1093/neuonc/now290. [Epub ahead of
print] PubMed PMID: 28096493.

4: Altinoz MA, Guloksuz S, Elmaci I. Rabies virus vaccine as an immune adjuvant
against cancers and glioblastoma: new studies may resurrect a neglected
potential. Clin Transl Oncol. 2017 Jan 16. doi: 10.1007/s12094-017-1613-6. [Epub
ahead of print] Review. PubMed PMID: 28093702.

5: Sun Y, Alberta JA, Pilarz C, Calligaris D, Chadwick EJ, Ramkissoon SH,
Ramkissoon LA, Garcia VM, Mazzola E, Goumnerova L, Kane M, Yao Z, Kieran MW,
Ligon KL, Hahn WC, Garraway LA, Rosen N, Gray NS, Agar NY, Buhrlage SJ, Segal RA,
Stiles CD. A brain-penetrant RAF dimer antagonist for the noncanonical BRAF
oncoprotein of pediatric low-grade astrocytomas. Neuro Oncol. 2017 Jan 12. pii:
now261. doi: 10.1093/neuonc/now261. [Epub ahead of print] PubMed PMID: 28082416.

6: Boetto J, Bielle F, Sanson M, Peyre M, Kalamarides M. SMO mutation status
defines a distinct and frequent molecular subgroup in olfactory groove
meningiomas. Neuro Oncol. 2017 Jan 12. pii: now276. doi: 10.1093/neuonc/now276.
[Epub ahead of print] PubMed PMID: 28082415.

7: Teng J, Carla da Hora C, Kantar RS, Nakano I, Wakimoto H, Batchelor TT,
Chiocca EA, Badr CE, Tannous BA. Dissecting inherent intratumor heterogeneity in
patient-derived glioblastoma culture models. Neuro Oncol. 2017 Jan 6. pii:
now253. doi: 10.1093/neuonc/now253. [Epub ahead of print] PubMed PMID: 28062830.

8: Zhu C, Mustafa D, Zheng PP, van der Weiden M, Sacchetti A, Brandt M, Chrifi I,
Tempel D, Leenen PJ, Duncker DJ, Cheng C, Kros JM. Activation of CECR1 in M2-like
TAMs promotes paracrine stimulation-mediated glial tumor progression. Neuro
Oncol. 2017 Jan 3. pii: now251. doi: 10.1093/neuonc/now251. [Epub ahead of print]
PubMed PMID: 28053137.

9: Darlix A, Gozé C, Rigau V, Bauchet L, Taillandier L, Duffau H. The
etiopathogenesis of diffuse low-grade gliomas. Crit Rev Oncol Hematol. 2017
Jan;109:51-62. doi: 10.1016/j.critrevonc.2016.11.014. Review. PubMed PMID:

10: Wei JW, Huang K, Yang C, Kang CS. Non-coding RNAs as regulators in
epigenetics (Review). Oncol Rep. 2017 Jan;37(1):3-9. doi: 10.3892/or.2016.5236.
PubMed PMID: 27841002.

11: Avila EK, Chamberlain M, Schiff D, Reijneveld JC, Armstrong TS, Ruda R, Wen
PY, Weller M, Koekkoek JA, Mittal S, Arakawa Y, Choucair A, Gonzalez-Martinez J,
MacDonald DR, Nishikawa R, Shah A, Vecht CJ, Warren P, van den Bent MJ, DeAngelis
LM. Seizure control as a new metric in assessing efficacy of tumor treatment in
low-grade glioma trials. Neuro Oncol. 2017 Jan;19(1):12-21. doi:
10.1093/neuonc/now190. Review. PubMed PMID: 27651472; PubMed Central PMCID:

12: Guidi M, Giunti L, Lucchesi M, Scoccianti S, Giglio S, Favre C, Oliveri G,
Sardi I. Brain tumors in Li-Fraumeni syndrome: a commentary and a case of a
gliosarcoma patient. Future Oncol. 2017 Jan;13(1):9-12. PubMed PMID: 27523101.

13: Hu LS, Ning S, Eschbacher JM, Baxter LC, Gaw N, Ranjbar S, Plasencia J, Dueck
AC, Peng S, Smith KA, Nakaji P, Karis JP, Quarles CC, Wu T, Loftus JC, Jenkins
RB, Sicotte H, Kollmeyer TM, O’Neill BP, Elmquist W, Hoxworth JM, Frakes D,
Sarkaria J, Swanson KR, Tran NL, Li J, Mitchell JR. Radiogenomics to characterize
regional genetic heterogeneity in glioblastoma. Neuro Oncol. 2017
Jan;19(1):128-137. doi: 10.1093/neuonc/now135. PubMed PMID: 27502248; PubMed
Central PMCID: PMC5193022.

14: Li S, Zeng A, Hu Q, Yan W, Liu Y, You Y. miR-423-5p contributes to a
malignant phenotype and temozolomide chemoresistance in glioblastomas. Neuro
Oncol. 2017 Jan;19(1):55-65. doi: 10.1093/neuonc/now129. PubMed PMID: 27471108;
PubMed Central PMCID: PMC5193021.

15: Goffart N, Lombard A, Lallemand F, Kroonen J, Nassen J, Di Valentin E,
Berendsen S, Dedobbeleer M, Willems E, Robe P, Bours V, Martin D, Martinive P,
Maquet P, Rogister B. CXCL12 mediates glioblastoma resistance to radiotherapy in
the subventricular zone. Neuro Oncol. 2017 Jan;19(1):66-77. doi:
10.1093/neuonc/now136. PubMed PMID: 27370398; PubMed Central PMCID: PMC5193023.

16: Zhang B, Chang K, Ramkissoon S, Tanguturi S, Bi WL, Reardon DA, Ligon KL,
Alexander BM, Wen PY, Huang RY. Multimodal MRI features predict isocitrate
dehydrogenase genotype in high-grade gliomas. Neuro Oncol. 2017
Jan;19(1):109-117. doi: 10.1093/neuonc/now121. PubMed PMID: 27353503; PubMed
Central PMCID: PMC5193019.